Calretinin is essential for mesothelioma cell growth/survival in vitro: A potential new target for malignant mesothelioma therapy?
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Calretinin is essential for mesothelioma cell growth/survival in vitro: A potential new target for malignant mesothelioma therapy?
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 133, Issue 9, Pages 2077-2088
Publisher
Wiley
Online
2013-04-18
DOI
10.1002/ijc.28218
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mesothelioma Not Associated With Asbestos Exposure
- (2012) Bharat Jasani et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Mechanism of capsaicin receptor TRPV1-mediated toxicity in pain-sensing neurons focusing on the effects of Na+/Ca2+ fluxes and the Ca2+-binding protein calretinin
- (2012) László Pecze et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Immunity and malignant mesothelioma: From mesothelial cell damage to tumor development and immune response-based therapies
- (2012) Valerio Izzi et al. CANCER LETTERS
- Calretinin Regulates Ca2+-dependent Inactivation and Facilitation of Cav2.1 Ca2+Channels through a Direct Interaction with the α12.1 Subunit
- (2012) Carl J. Christel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An Extracellular Signal–Regulated Kinase 2 Survival Pathway Mediates Resistance of Human Mesothelioma Cells to Asbestos-Induced Injury
- (2011) Arti Shukla et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Epithelial-to-mesenchymal transition, cell polarity and stemness-associated features in malignant pleural mesothelioma
- (2011) Claudia Casarsa et al. CANCER LETTERS
- Calcium and cell death mechanisms: A perspective from the cell death community
- (2011) Boris Zhivotovsky et al. CELL CALCIUM
- Molecular Pathways: Targeting Mechanisms of Asbestos and Erionite Carcinogenesis in Mesothelioma
- (2011) M. Carbone et al. CLINICAL CANCER RESEARCH
- Gene Therapy for Mesothelioma
- (2011) Anil Vachani et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Malignant mesothelioma: Facts, Myths, and Hypotheses
- (2011) Michele Carbone et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Epithelial–mesenchymal transition in malignant mesothelioma
- (2011) Ambrogio Fassina et al. MODERN PATHOLOGY
- Simian virus 40 transformation, malignant mesothelioma and brain tumors
- (2011) Fang Qi et al. Expert Review of Respiratory Medicine
- Sarcomatoid mesothelioma: a clinical–pathologic correlation of 326 cases
- (2010) Sonja Klebe et al. MODERN PATHOLOGY
- Cytosolic Ca2+ Buffers
- (2010) B. Schwaller Cold Spring Harbor Perspectives in Biology
- SV40-Induced Expression of Calretinin Protects Mesothelial Cells from Asbestos Cytotoxicity and May Be a Key Factor Contributing to Mesothelioma Pathogenesis
- (2009) Thomas Henzi et al. AMERICAN JOURNAL OF PATHOLOGY
- Prognostic significance of epithelial–mesenchymal transition in malignant pleural mesothelioma☆☆☆
- (2009) Alexandra Schramm et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Malignant pleural mesothelioma: current treatments and emerging drugs
- (2009) Carmen Belli et al. EXPERT OPINION ON EMERGING DRUGS
- Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors
- (2009) Robert H Kutner et al. Nature Protocols
- Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression
- (2008) Asako Sakaue-Sawano et al. CELL
- The continuing disappearance of “pure” Ca2+ buffers
- (2008) B. Schwaller CELLULAR AND MOLECULAR LIFE SCIENCES
- Mesothelioma Epidemiology, Carcinogenesis, and Pathogenesis
- (2008) Haining Yang et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started